Hemispherx BioPharma (HEB)

[ehihub]

Ive just watched all the YouTube video interviews with Hemispherx CEO Thomas Equels. This guy gets it done and I like his views on “shareholder value” and “being non-dilutive” in his approach to finance. He has reduced the burn rate by over 50% and is hitting many milestones.
The company has orphan drug status (7 years exclusivity). They are in phase 3 clinical trials with Ampligen (easy to manufacture by the way) and FDA approval basically could happen at anytime. There other already FDA approved drug, Alferon, has gone under a manufacturing process upgrade and is waiting FDA approval of the new process. Basically they went from manually making the product to automation and it requires re- certification by the FDA. Shipping out the new product as early as March 2018. So money coming into the company. Awesome!

These drugs can be used in multiple stand alone and mixed in “cocktails with other drugs.

That means the potential market is worth billions. IMO, and the CEOs.

I highly recommend watching all the interviews and get educated about the potential market for HEB.